[1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[2] |
WANG Siyu, LI Jiawei, LI Chenghao, LI Ling, GUO Qingyang, QIU Lu, ZHOU Shiqin, LIU Yongqi.
Research progress of lactate dehydrogenase A in digestive system tumors and related drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 445-454.
|
[3] |
CAI Zuhuan, DENG Taomei, WEI Naijie, ZHU Dan, QIAN Fei, WANG Guangji, ZHANG Jingwei.
Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 241-248.
|
[4] |
SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju.
Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262.
|
[5] |
LIU Yizhen, REN Lingxuan, YANG Jianjun, HE Jianyu, LIU Xiaojun, WANG Long, LIN Rong.
Study on the screening of active constituents of Taohong Siwu Decoction and the protective effect of ferulic acid on myocardial injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 505-515.
|
[6] |
DONG Wei, HUANG Xiaoying, XIE Bingbin, TANG Xilan, LI Hongming, QIU Yumei, ZHAO Guowei, LIANG Xinli.
Effects of oxypeucedanin on the resistance of breast cancer MCF-7/DOX cells to doxorubicin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 260-266.
|
[7] |
WEI Jifang, YUE Hongmei, LIU Nanyu, SONG Peipei, XIE Yingying, WANG Jiaqi, WEI Yaqian.
Research progress on the relationship between thyroid hormone and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307-313.
|
[8] |
DU Chen, TIAN He, CAO Yang, WANG Yongjun, ZHANG Yan.
Research progress on bone metabolism disorders associated with PCOS elucidated from endocrine hormones
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 328-333.
|
[9] |
ZHANG Liang, LIAO Yongqun, XIA Qinchuan, ZHOU Shitong, LI Xiaoli.
Ferroptosis regulatory signaling pathway and its research progress in related diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 227-234.
|
[10] |
CHEN Yu, GU Bing, LI Huanan.
Modulating gut miocrobiota: a new strategy in the treatment of gout
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1307-1314.
|
[11] |
LI Lingling, ZHANG Yangyang, BAI Jia, YANG Hong, YANG Ying, LV Haihong.
Progress in research on the effects of different glucagon-like peptide-1 receptor agonists on bone metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1315-1320.
|
[12] |
GUO Yuting, LI Shanshan, LI Qinglin.
Tianma Gouteng Yin protects rotenone-induced PC12 cell damage by inhibiting ferroptosis-lipid metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 8-14.
|
[13] |
ZHANG Yuanjin, HUANG Shengbo, LIU Jie, WANG Xin.
Construction and application of innovation gene-edited rats and intestinal 3D organoids models in drug metabolism and pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 914-922.
|
[14] |
YANG Hechun, SHI Daohua .
Research progress of small molecule inhibitors that reverse tumor drug resistance by regulating tumor glucose metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 836-840.
|
[15] |
WANG Ping, SHEN Jie, CHU Jiru, GUO Nan, XIE Haitang, ZHAN Cuijiao, WANG Changmao, YANG Bin, ZHENG Dandan, HU Rongfeng, JIA Yuanwei.
Segmental absorption of helicid in rat everted intestinal sac model: A preliminary study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 258-263.
|